Arcosa (ACA)
(Delayed Data from NYSE)
$103.86 USD
+0.70 (0.68%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $103.84 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$103.86 USD
+0.70 (0.68%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $103.84 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Zacks News
Are Investors Undervaluing Arcosa (ACA) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Arcosa (ACA) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Arcosa (ACA) delivered earnings and revenue surprises of 32.73% and 0.04%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
When Does Market Timing Actually Work? - July 27, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Earnings Preview: Arcosa (ACA) Q2 Earnings Expected to Decline
by Zacks Equity Research
Arcosa (ACA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
When Does Market Timing Actually Work? - July 08, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Installed Building (IBP) Buys Nationwide Gutter for Expansion
by Zacks Equity Research
Installed Building Products' (IBP) acquisition of Nationwide Gutter is set to expand its footprint in Texas.
PGT Innovations Unveils Non-Impact Entry Door & Window Wall
by Zacks Equity Research
PGT Innovations' (PGTI) brand CGI Commercial unveils two new professional-grade non-impact products. Its innovation and expansion bode well.
The Truth About Market Timing - June 12, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Timing the Market, Is it Possible? - May 27, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
PGT Innovations (PGTI) Stock Up 26.4% on Q1 Earnings Beat
by Zacks Equity Research
Higher sales growth and margins owing to prudent cost control and operating efficiencies help PGT Innovations (PGTI) to post better-than-expected Q1 earnings and revenues.
When Does Market Timing Actually Work? - May 06, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Aegion's (AEGN) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Aegion's (AEGN) Q1 results primarily reflect higher margins across Infrastructure Solutions and Energy Services segments.
Arcosa (ACA) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Arcosa (ACA) delivered earnings and revenue surprises of 47.92% and 2.80%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Masco (MAS) Revokes 2020 Guidance Amid Coronavirus Pandemic
by Zacks Equity Research
Masco (MAS) withdraws its 2020 guidance in response to the rapidly changing macro-economic conditions.
Arcosa (ACA) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Arcosa (ACA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ACA vs. ROAD: Which Stock Is the Better Value Option?
by Zacks Equity Research
ACA vs. ROAD: Which Stock Is the Better Value Option?
The Truth About Market Timing - April 08, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Yes, You Can Time the Market. Find out How - March 19, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
TopBuild (BLD) Rides on Acquisitions, Higher Selling Prices
by Zacks Equity Research
Solid growth across the business, favorable industry parameters and strategic initiatives aid TopBuild (BLD) to generate higher profits.
Installed Building (IBP) Buys Royals Commercial for Expansion
by Zacks Equity Research
Installed Building Products' (IBP) acquisition strategy is set to boost its geographical boundaries and product offerings.
Masco Banks on Repair & Remodeling Business Amid High Costs
by Zacks Equity Research
The repair and remodel business, as well as focus on streamlining portfolio are likely to drive Masco's (MAS) growth. However, softness in markets served and higher costs are concerns.
Gibraltar (ROCK) Shares Up More Than 4% on Q4 Earnings Beat
by Zacks Equity Research
The acquisition of Apeks Supercritical, and solid contribution from Renewable Energy and Conservation segments help Gibraltar Industries (ROCK) to post better-than-expected Q4 earnings.
Are Investors Undervaluing Arcosa (ACA) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Aegion's (AEGN) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Aegion's (AEGN) Q4 results primarily reflect lower contribution from Corrosion Protection.
Arcosa (ACA) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Arcosa (ACA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).